OMA Guidelines Bundle

Obesity Pharmacotherapy - Obesity Algorithm 2024

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1349812

Contents of this Issue

Navigation

Page 33 of 33

Abbreviations ADHD, attention deficit hyperactivity disorder; ALA, alpha lipoic acid; BED, binge-eating disorder; BID, two times a day; BMI, body mass index; CA, cancer; CGRP, calcitonin gene-related peptide receptor; CLA, conjugated linoleic acid; CVD, cardiovascular disease; DEA, Drug Enforcement Administration; DPP4, dipeptidyl peptidase-4; EGCG, epigallocatechin gallate; FDA, Food and Drug Administration; GFR, glomerular filtration rate; GIP, glucose-dependent insulinotropic peptide; GLP-1 RA, glucagon-like peptide-1 receptor agonist; HAART, highly active antiretroviral therapies; HCG, human chorionic gonadotropin; HCl, phentermine hydrochloride; HDL, high-density lipoprotein; HIV, human immunodeficiency virus; LEPR, leptin receptor; MAOI, monoamine oxidase inhibitor; MEN, multiple endocrine neoplasia syndrome; MEN 2, multiple endocrine neoplasia syndrome type 2; mTOR, mammalian target of rapamycin; NSAIDs, non-steroidal anti-inflammatory drugs; ORC, obesity-related complication(s); OTC, over-the-counter; PCSK1, proprotein convertase subtilisin/kexin type 1; POMC, proopiomelanocortin; PPA, phenylpropanolamine; TMAO, trimethylamine N-oxide; USP, United States Pharmacopeia Source Tondt J, Freshwater M, Benson-Davies S, Dawkins C, Magee J, Karjoo S, Ortiz Page, SO, Pile H, Khan N, Hurtado Andrade M, Rajpal A, Petcu A, Antoun J, Haq H, Fryoux E, Gugnani K, Manek M, Aranas MP, Afreen S. Obesity Algorithm Slides, presented by the Obesity Medicine Association. www.obesityalgorithm.org. 2024. https://obesitymedicine.org/obesity- algorithm. (Accessed = Feburary 2024) Disclaimer is resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers aer consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary. 1258 Upsala Rd Sanford, FL 32771 TEL: 407.878.7606 FAX: 407.878.7611 Copyright © 2024 All rights reserved Obesity Medicine Association 7173 S. Havana St #600–130 Centennial, CO 80112 TEL: 303.770.2526 OMAOBEPS03242b

Articles in this issue

Links on this page

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity Pharmacotherapy - Obesity Algorithm 2024